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INTHODUCTION 
Although t~ere is reference in literature of the 
Nineteenth Century to syndromes similating the disease 
(granulocytopenia) 9.8 W(~ know it todes, it "vas not un-
til the year 1922 that Schultz 8ctually described his 
C8se as a disease entity and by so doing, stimulated 
the interest of tne medical profession to further in-
vestigation. This preliminary investigation has re-
sulted in unlimited publications on the various phases 
of granulocytopenia and, as with any recently recognized 
d1 seF.tse, h8 s flooded the literature with numerous hypo-
theses as to the etiology and rationale of treatment, 
some of which are rather bizarre, other of ~hich are 
very logical, but all of which ere necessary steps in 
the clarification of such an uncertain disease. After 
reviewing the literature on the subject, it is quite 
apparent that the finel ~ord has not BB yet been writ-
ten but that the work of the last five yeers has seem-
ingly accomplished the most toward that end. 
In this paper an attempt will be made to correlate 
the various manifestations of the disease with special 
refer ence to etiology, pathology and trea,trnent. No at-
tempt is made in this paper to discuss the grBnulopenic 
syndrome under the various classifications that have been 
suggested because no classificetion has as yet been ad-
vanced which is satisfactory. 
1 
DEFINITION 
Gra.nulocytic cytopenia is a greve disease in-
volving a number of disputed etiological factors and 
characterized by a marked reduction in total number of 
white cells with a complete or nearly complete reduc-
tion in the percentage of granulocytes, accompanied by 
aplastic, normal, or hyperplastic myeloid tissue. 
Following the peripheral granulopenit:l there may be any 
number of lesions or symptoms which might follow the 
removal from the body of such an important defense me-
chanism. The disease may be acute, recurrent, or 
chronic. 
This definition is taken with modification from 
an article published in the Journal of The American 
Medical Association of 1933 by Regina C. Beck, M. D. 
(1 ) 
HISTORY 
As stated in THE JOURNAL (2), the first description 
of a condition simileting granulocytic cytopenia was 
made by Turk in 1907. However Turk failed to clistin-
guish his c?ses from the commoner leukopenia of over-
whelming infection. This suggestion made by Turk ap-
2 
parently did not stimulate sufficient interest for 
further study until 1922 when 1Nerner Schultz, (3) des-
cribed a number 'of CB.ses which revealed an almost com-
plete absence of gre.nular cells a ssocie.ted with 8. group 
of pathological findings and symptoms which he declared 
formed a. clinical entity. It wa s not until the follow-
ing year that Friedmann gave the name of agranulocytic 
angina to this syndrome described by Schultz. (4) 
Although there is no reference to earlier descrip-
tion of a syndrome which can definitely be classed as 
granulocytic cytopenia. However there is no doubt that 
such a symptom complex was described before 1907. As 
early as 1857, Gubler described a gangrenous angina 
which he differentiated from diphtheria, and in 1865 
Trousseau published 8. similar description. (5) Morrell 
Me.ckenzie (6) in 1880, in his "Manua.l of Diseases of 
the Thros.t and Nose", described a gangrene of the phar-
ynx, distinguished it from diphtheria and scarlet fever, 
and ca.lled it ttputrid sore thro~lttl. This term we.s used 
commonly for about twenty years thereafter. 
Pepper (4) states, "It is further interesting to 
note that by the beginning of the new century the text-
books of nose and throat diseases had begun to omit the 
heading '·putrid sore throatlt,. until by the time Schultz 
described the syndrome there was no description in the 
text-books which corresponded at all to the picture of 
agranulocytic angina. In recent text-books, of course, 
this omission has been rectified by the description of 
the syndrome under its present name." 
Since 1922 there has been a constant and increas-
ing study of this disease. In 1927, Kastlin (7) col-
lected reports of 43 cases and reported two more, with 
only three recoveries, a mortality of 93 'Dsr cent. 
Kastlin believed tl:E t the di sea se ws.s not a clincial 
entity because of t he variations in the cases reported. 
Blumer (8) in 1930 reported a case beginning with nu-
merous bOils ths.t became le.rge abscesses, the blood and 
the clinical course essentially the same as in the cases 
described by Schultz. Harkins (9) reported eight ca. ses, 
four of which he considered to be agranulocytic angina 
and the other four of which he celled granulocytopenia 
because of the anemia and hemorrhagic diathesis, al-
though it answered Schultz's description otherwise. 
Farley (10) ha s collected report s of s. serie s of csses 
following the administration of arsphenamine, which had 
an agranulocytic period following the therapy • 
• It is clear that there may be a variety of condi-
tions associated with the low granulocyte count. Stocke 
(11) in 1930 divided the cases into three groups; one 
group answering the description of Schultz, a second 
showing the presence of anemia, and the third a tenden-
cy to hemorrhage. 
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B~cteriologic study has not as yet yielded 
anything definite. Friedmann isolated Bacillus Pyo-
cyaneus from the blood stream once. (2) Lovett (12) 
fout;ld the SBme organism in the throat and determined 
that the isolated organism in the throat caused a rel-
ative lowering of' the granulocyte count in rabbits. 
Dasse (13) found the organism in the throat in almost 
pure culture and confirmed Lovett's animal experiments. 
Since Kastlin's report of forty-three cases in 
1937 ~ there has been a marked incres.se in the number of 
cases reported and in 1934 Madison and Squier (14) esti-
mated that there were over five hundred cases on record. 
In the last few years, along with the increasing 
incidence and increasing number of cases reported, there 
has been an unlimited amount of material written on the 
different phases of the disease and much progress has 
been made toward solving the etiology, as well BS in 
the treatment of the disease. 
NOMENCLATURE 
Werner Schultz (3), in 1922 proposed the name a-
granulocytosis. The supply of hematologic terms is sO 
abunda .. nt that there is little excuse of choosing such 
an a.mbiguous term. The term Cl8.me into the nomenclature 
'5 
no doubt, on account of its brevity. Schultz undoubt-
edly chose the word agranulocyte to describe "neutro .... 
phils without granulation" which he had spen in blood 
smea~s from eases of leukemia (1). Friedmann (15) 
being impressed by the usual severe localization of the 
process in the throat, suggested the name angina agran-
ulocytica. This name was likewise unfortunate in that 
it implies that the granulocytopenia is a result of the 
angina rather than a syndrome of unknown etiology_ It 
is now known that cases do rarely occur without a.ngins .• 
Baldridge and Needles (16) pointed out that if the der-
iva.tion of egranulocytosis is a.ssumed to be agranulo-
cyteosis it would me~m an increased number of these very 
special abnormal neutrophils. On the other h?nd, if 
the derivation is a-granulocyte-osis it would mean ~1n 
absence of increase granulo cytes, or a normal count. 
They, therefore suggested the name Idiopa.thic neutro-
penia, thus making it analegous to idiopa.thic aplastic 
anemia and idiopa.thic thromboctopenia.. Kracke (17) 
brought out the term granulocytopenia as more exactly 
expressing the actual condition existing in the disease. 
Boerner's (18) nomenclature is widely accepted and is 
consistent with that of Kracke's. His nomencls.ture 
describes both variations in numbers and percentages 
of white blood cells. It is as follows: 
r 
o 
NEU'rHOPENIA-""a decrease in neutrophils 
LYMPHOPENIA--a. decrease in lymphocytes 
GRANULOPENIA--a decrease in granulocytes 
The terms suggested is fitting to such a classification 
and expressive of the pathology. Ma.ny terms have been 
suggested, some o-f which are: (1) Mucositis necroticans 
agranulocytica, monocytic angina, sepsis with granulo-
cytopenia, and agranulosis. Some of the better names 
that have been suggested are: idiopa.thic neutopeni~l 
by Baldridge and :Needles (16) malignant neutropenia 
by Schilling (19), ma.lignant (fa.tal) and benign (re-
covered) neutropenia by Rosenthal, granulopenia by 
Boerner (18), 2nd gr8nulocytopenia by Kracke. (17) 
If a term were to be used which would most a.cura.te-
1y coincide with the definition of the disease one 
would be forced to admit that granulocytopenia would 
be the most fitting term. It not only accurately des-
cribes the dieease but also, by similarity of name, is 
suggestive of the misleading but more widely used terms 
of agranulocytosis and agranulocytie angina. For these 
reasons, this syndrome will hereafter be referred to as 
granulocytopenia. 
CLASSn~ICATION 
When Schultz (3) first described his cases of "a_ 
granulocytic smginal' he thought them to be a. disease en-
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tity end it is still regarded as such of some authors. 
(21) Sc~ultz described only the rapidly fatal type snd 
thought it to be s. di sea se peculiar to women around for-
ty who were approaching the menopause. However, since 
that time m~my excellent articles have appepred in the 
literature tending to prove that there are different 
ph~£88 of this malady, and that. it is well to classify 
them under the primary and secondary types. Kracke (17), 
Roberts and Kracke (22), end likewise Piersol and 
Steinfield (23) have classified the different types of 
granulocytopenia in a most excellent mlSmner. Roberts 
and Kracke classify them 8S follows: 
1. Agranulocytic states due to che~ic~l~ 
pOisons, as benzene or arsenic. Agran~ 
ulotoxicosis. 
2. Agranulocytic stetes due to bacterial 
infection. Agranulosepsis. 
3. Agranulocytic states due to irradiation, 
as 8.fter radium and x-ray. Agrenulo-
radiation. 
4. Agranulocytoxis, a disease entity, in 
which an unkown casue results in marrow, 
b~ood, and clinical onsets in the order 
named and characterized by single or re-
current acute attacks. 
5. Aplastic anemia, with or without acute 
terminal infection. 
6. Pernicious anemia, terminal stAte. 
7. Acute aleukemic lymphatic leukemia with 
or without acute terminal infection. 
8. Bizarre anemias and bizarre proportions 
of the lymphocyte and monocytes. 
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9. Roseola infantilis. 
10. Acute infectious diseases associated 
with or followed by leukopenia and 
rar~ly near agranulocytic states--
typhus, typhoid, mumpe, measles, mala-
ria", influenz,a, dengue, phlebotomus 
fever, Eygptian splenomegaly, and 
certain pneumonias. 
Piersol and Steinfield (23) believe that the syn-
drome described by Schultz merits the terms of prime.ry. 
granulopenia, and that instances without discoverable 
cause and corresponding to his original description 
should properly fit into this cl':ttegory. The term sec-
ondary grt:lOulopenia., they think, seems appropriate for 
the larger group of cases due, to known causee. The 
term primary granulopenia therefore, seems to corres~ 
pond favorably with number (4) or (Agranulocytosis) 
of Roberts and Krackets classification. Piersol: and 
Steinfield suggested the following classification: 
PRI~~RY GRANULOPENIA 
1. Acute (Schultz) 
2. Chronic (recurrent) 
SECONDAHY GRANULOPENIA 
1. General infections 
Influenza, 
Typhoid 
Some exanthemasa 
Q • t )",Iepsls, e c •. 
2. Foeal infections. 
3. Chemical (arsphenamine, 
benzene). 
4. Irradiation (x-rays, 
radium). 
5. Blood diseases (leuk-
emia, spleenic dis-
ease, aplastic anemia, 
etc. ) • 
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Sachs (21) fee,ls thAt the primary group should be 
divided into the acute, subacute, and chronic recurrent. 
He adds the subacute because two of his cases were sub-
acute and not of a chronic recurring nature. 
Rosenthal (20) in his classific~tion made etcording 
to the clinci8l manisfeststions and course, divided neutro-
penia into malignant (fatal) and benign (recovered) cases. 
Beck (1) suggests that it might be well to divide these 
into two main classes as follows: (1) primary benign 
and primary malignant neutropenia, in which the etiology 
is unknown; (2) secondRry benign and secondary rnalig-
nant neutropenia, the cases in which the etiologic agents 
are evident or in which one is dealing with examples of 
well recognized clinical entities. 
Madisonts classification is similar to that of 
Piersol and Steinfield except that he adds another sub-
division to that of secondary granulopenias, namely, 
that of allergy. However he admits that the question 
of allergy is still far from settled insofar as its 
etiological roll is concerned. 
From the above, it is quite evident' how unsatisfac-
tory attempts at £1 classification of this disease. have 
been. The numerous classifications suggested all are 
based on an etiological baeis and as the etiology of 
this disease is still quite Obscure, is it not foolhardy 
~ 
to attempt to classify the disease on such a basis? 
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PHYSIOLOGY 
Much of the accuracy in interpretation of the 
blood picture in cUsease is dependent upon an understand-
ing 0:1:' the underlying mechanism of hemopoesis. The .many 
technics which have been developed for the study of the 
cells of the blood, together with data on cell origins 
and differentation obte.ined from embryologic and experi-
mental investigations, now provide at least a working 
basis for the approach of the dyscrasias involving the 
hemopoetic system. There are very few pathological con-
ditions with which the body has to det:tl, in which one, 
or more, of the types of cells represented in the cir-
culating blood is not secondarily involved. That these 
circulating cellular elements ~ay represent an import-
ant ~:md powerful increment in the defense forces of the 
body is a fa.ct attested by repeated observB.tion. 
Lowell Gulla.nd (25) looks forward to the time when the 
differential count will be more important tha.n the 8.US-
cultation of the heart. 
Maximow( 26} describes the granulocytes in the fOl-
lowing' manner. In contra.st to the lymphocytes and mono-
cytes, the granulocytes alvvays contain granules elebo-
reted in their protoplasm. These gra.nules are the same 
in a. given cell but VtU'y in different species and in 
the different cells of the same species. Another gen-
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eral characteristic of the mature granulocyte is the 
shape of its nucleus, it being lobated instead of con-
stricted or spherical as in the monocyte and l~yphocyte. 
The granulocytes fall into three gener!:tl group$desig-
nB.ted as: (l) acidophil, (2) basophil, a.nd (3) heter-
ophil leucocytes~ In the first the granules in the 
protoplasm are most often spherical or oval and are e-
lectively stained with acid dyes; in the s~cond, they 
are of similar form, but stain electively wtth basic 
dyes; While in the third group the granule$, although 
constant in particular species, differ as tq form, size, 
and staining reaction according to species. 
One of the striking properties of the leucocyte is 
amebism. This property is most prominent in the heter-
ophils. The amebism probably expl8ins in p,rt why the 
leucocytes are not confined to the system of blood or 
lymph vessels, but may be found everywhere in the tis-
sues. The leucocytes, in all probability p$rform their 
I 
functions only when outside the wascular system. If 
I 
these cells are needed in any place of the ~rganism, 
they assemble rapidly in the blood vessels 9f the region 
and migrate into the tissues. 
The phagocytic activity of the leucocy~e is inti-
mately connected with its amebi sm and a s one- would expect 
is most pronounced in the heterophils. Phagocytosis is 
of great biological importance a.s it is one of the meE;ms 
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by which ~he host destroys bacteria. 
It has 8.180 been shown tte t the heterophil gr~m .. 
ulocytes contain proteolytic and oxidizing enzymes. 
The eosinophils display phagocytosis rarley if ever; 
however their granules give a marked oxidase reaction. 
The function of the baso phils and the cherild:cal nature 
of their granules is unknown. 
Roberts ~md Kracke (22) have found that the loss 
of the granulocytes from the body for seven days is in-
compatible with life •. Granulocytes are one of the chief 
sources of immunity, and with their disintegration and 
release of ferments, they give much a.ctive da~ly immunity 
to the body_ The heterophils are also thought to be the 
source of complement as well as the various immune bodies 
such as hemolysins, precipitins and baeteriolysins. (1) 
The life span of the neutrophil in the blood stream 
has been shown to be approximately four days _ (22) IProm 
this some idea can be obtained of the enormous numbers 
of granulocytes consumed daily by physiological degen-
eration. 
'rhe bone marrow throughout extra-uterine Ii fe is 
the natural source of erythrocytes, thrombocytes, and 
the three types of granulocytes. (27) The phagocytic 
macrophages (clasmatocytes), while always present in 
the marrow, are quite as regularly and normally found 
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in spleen, liver, and diffuse connective tissues of 
the body. However their size and ability to arise 
in situ throughout the body, as the need presents, 
tends to minimize their appearance in the circulation. 
(28) (29) Lymphocytes and monocytes, the remaining 
elements, which utilize the vascular bed as an avenue 
of distribution, develop in the lymph nodes, "Spleen, 
and in the more diffuse lymphoid ana. connective tis-
sues of the body. Hence, hemopoesis in its broadest 
sense involves bone marrow, spleen, lymph nodes, con-
nective tissue and the vascular and lymphatic systems. 
(27) 
Confusion has existed, and still prevails, among 
hematologists relative to the origins and relationships 
of the cells of the blood. Rov/ever it is agreed that 
!ll take their first beginning from the mesenchymal cells 
of the mesoderms~l layer in the embryo. But thereafter 
the theories and hypotheses diverge more or less rs,di-
c8.l1y; however the essentia.l differences a.rise more 
in the interpretation and nomenclature than in opposing 
. objective observations. In the usual hyperplastic reo. 
marrow, where blood cells are developing, it is diffi-
cult to distinguish the tissue landmarks, which separate 
and segregate the units comprisi ng different cell stra ins. 
This difficulty has been obviated by certain investigators 
through a study of less complex areas, either experiment-
ally pro~uced (30) (31) or naturally occuring, as in the 
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zone between red and yellow me.rrow when hemopoesis is 
extending. (32) Under these conditions erythrogenesis 
has been observed to. occur in foci separate and dis-
tinct from myelogenic centers !md it is from this rna ... 
terial that we have learned most about the relative 
location, distribution, ~md independent origin of er-
ythrocytes and gra.nulocytes. One of the 'principal dif 
ficulties to an unanimous egreerr:ent upon these inter-
cellular relationships resides in the fact that the 
all of the cells of the blood continue to arise threugh-
out life as primitive, immature elements incapable of 
performing thei,r specific functions until after comple-
tion af p definite maturation'cycle. Most of the cri-
teria characteristic of the definitive cells, and which 
form the be. sis for morphological differentiation and 
elassification, areelaboreted during this maturation 
period. Hence, the earli-er precursors of each strain 
of cells lack, in direct proportion to their immaturity, 
clear cut distinguishing' features upon which hemetolo-
gists can agree. 
Ma.ximow (33), in his studies, including both embry-
onic end adult tissues, was convinced of the hemocyto-
genic function of the "1ymphocyte it , in which exits 80le-
ly to be played' upon by the vprious forces of the body, 
with the corresponding cellular differentiation being 
a direct result of the need of the moment. Cunningham, 
Sabin, and D08n (34) conclude from their studies that 
a primitive stem cell for the white blood cells may be 
recO 
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recognized in the bone marrow, lymph nodes, spleen, 
end connective tissues. Fixed cells in the reticulum 
of these orgpns give rise by mitosis to a free prim-
itive cell, the size of the sIDall lymphocyte. During 
times of increased demand for myeloid or lymphoid ele-
ment s these small round. cell s m2'y be found increB sed 
in number in 8.ssociBtion with the more mature cells of 
the respective streins. Their studies differentiate 
this primitive stem cell from the lymphocyte, which 
they observed to develop into other definitive forms. 
Numerous authors have taken sides with either one or 
the other hypotheses. l'[ay it suffice to say, that 
our pre~ent information justifies both the position 
taken by those who h8ve contended thl?t the "lymphocyte-
like" cells may differentiate into otherspeclfic de-
finitive cell types, Bnd thos~ who have seen no evidence 
of such a transformation. Those who have used the super-
avi,tal and fixed techniques extensively together feel 
that the early precursors of the Hlymphoc3tt"B cycle, the 
lymphobj..asts, me.y be distinguished from the "primitive 
stem celi lt of the whites and also from the myelobllClst 
Bnd monoble st. (34) They claim th8.t the lymphobla st s 
have a relativelY deeper basophilia, larger rod shaped 
mitochondria, and fewer nucleoli (one or two) than do 
the leucoblasts of the other two strains of white cells. 
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Nei ther hypothesis may be considered fl.8 mutua.lly ex-
eluding the other, but rather the difference seems to 
be a. question of interpreting just where, if at all, 
specificity begins and reversible dedifferentiation 
becomes impossible. 
The above diagram by Sebin (35) expresses very com .... 
pletely certain c~iteria in the maturation process of 
the granulocyte. On this chart matur8tion is represent-
ed as a series of varying factors, constantly changing. 
In some levels, the factors may increase together, in 
others, some may increase while others decrease. 
Sabin gives the following explanation of the chart. 
Level I is best studied in a completely aplastic adult 
17 
bone marrow from w'hich 8.cti ve marrow is readily end 
quickly regenerated. (31) In such a Duiescent marrow, 
only three types of cells can be seen: fat, endothe-
lium,. and reticulum. Of these three, the fat is but 
accessory to blood formation. Evidence indicates tha.t 
the red cells regenerate from the endothelium, while 
the white cells regenerate from the reticulum. 
The reticular cells Bre ea.sl1y found because they 
are the only cells lying between the fat cells along 
the reticu18r framework. The nuclie he.ve so Ii ttle 
chroma tin as to make them scarcely more ba sophilic tha.n 
the cytoplasm. These cells Bre probably as close to 
primitive embryonic mensenchyme as occurs in the adult 
animal. MaTI'cry (36) describes the reticular cells as 
a type less differentiated than the fibroblast but also 
says they may differentiate into a fibroblast. These 
reticular cells were described by Cunningham and others 
(37) as to there charecterietics and relation to the 
origin of the white blood cells. These cells can always 
be found in bone marrow, lymph glands, a.nd spleen, and 
have been reported along the blood vessels in connective 
and brain tissues, and nervous tissues in general. (38) 
In reSeneratingvmarrow, this primitive reticular cell, 
with repeated divisions, gives rise to a primitive free 
cell. In this process, a few mitochondria are elaborated 
in the cytoplasm and basophilia gradually develops. (37) 
i 
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Finally, as' the basophilia of the cytoplasma and the 
numbers of the mitochondria reach a maximum the cell 
becomes.a myeloblest. It is this small primitive free 
cell which has caused so much confusion in hematology 
because of its similarity morphologicB.lly to the small 
mBture lymphocyte'. 
The classific2tion of the myelocytes, Level II, 
by the number of granules was introduced by Cunningha.m, 
Sabin, Austrian, pnd Doan. (39) Myelocyte type A is 
derived from the myeloblast. It is of maximum baso-
philia and mitochondria but contains 13. minimum of gr~m ... 
ulation. Type B represents the stage during which gran-
ulation is increasing, while Type Cis the stage at which 
granulF-ltion reaches its maximum. The conventional class-
ification of Level II is promylocyte and myelocyte de-
pending on the changing chemistry of the granules. At 
the end of Level I I be sophilia and cell di vi si on ces.ses 
while amoeboid activity is i?itiated. The cell first 
showing a.moeboid movement is termed a metamyelooyte. 
The third level, marking the end of maturation, is 
characterized by cells of 8 pproxim~ltely uniform size 
and content of specific granule.tion. These factors mean 
functional maturity. The nuclei fragr:J.ent, but cell di-
vi sion he s c ea sed. The leucocytes become more ma.ture 
in the circulating blOOd and finally pass into the 
Arneth pattern involving muclear changes and finally in-
19 
to the non-motile, fragile forms. 
Granulopoesis occurs in the more vascular 8~reas 
and develops around the patent sinuses a.nd moves toward 
their borders as the cells become more mature; in con-
trast to the red cells "';thich develop in the area of the 
closed sinuses, the more mature cells moving toward the 
center of the sinusoid. 
With the concept in mind that bone marrow as an . 
organ is the place where two types of cells are made, 
that it holds a large store of each strain almost ready 
for delivery, a.nd that its store of immature forms is 
small in numbers, but of exceedingly high potentiality 
toward multiplication, growth, and maturation, the 
question of the mecha.nism whereby a normal structure in 
both the marrow and blood is maintained becomes the ma-
jor problem of hematology. 
Doan (40) and others have shown that vlhatever con-
trols the proportion of collapsed capillaries to open 
sinuses is an important factor in the regulation of the 
proportion of red cells to myeloid elements in the mar-
row, the ratio being directly proportional. This mech-
anism, they claim, involves both vasomoter a nd chemical 
control. Doan And Zerfas (41) give the following rnye-
loid--erythroid ratios: 80:5, 80:4, and 71:13. Sa.bin 
(35) after analyzing the works of Krogh, Hooker, Rich8rds, 
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Rich 8.nd others, < stetes that it is not clear what part 
the v8.somote!' nerves and what pert chemical stimulB.tion 
of the local endothelium plays in collapsing the sinuses. 
Besides the factors controlling the mechanism of 
maturation, one must also consider the mech~Jnism of de ... 
livery of the cells to the circulation. Sabin (35) finds 
that for a.dmission of cells into the circulation two 
structures are involved: the endothelial walls of the 
sinuses, and the blood cells themselves. The granulo-
cytes, as maturation progresses tend to become massed 
against the capillary wall and eventually bend it in-
ward unt il finally the tense membr~me ruptures between 
two endothelial cells. The number of leucocytes in the 
blQod is dependent upon two factors: first, the rAte 
of maturation, and secondly, the rete of delivery into 
the blood. Sabin (35) calls the second factor, a cheme-
tactic factor (0) while the former she de~ignates BS a 
maturation factor (V}. Doan and others (40) have ad-
minstered inactlvRted typhoid b8cilJ i to a rB.bbi t and 
followed the blood th~ough the stages of leucocytosis. 
The marrow was finally found :entirely depleted of mye-
locytes C and E Bnd reduced to a low level of amydlo-
cytes A and myeloblasts. ~'32bin (35) expresses their 
results as a condition due to a chemotactic factor 
minus a matur8tion element. This concept of leucocy-
tosis and leucopenia postulates the infecting organism 
as introducing both B chemotactic and B maturation fa-
ctor when leucocytosis results and chemotactic factor 
8"10ne when B leucopenia follows B. temporary leucocytosis. 
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An important contribution on the subject of chem-
otaxis was introduced in 1928 by Doan, Zerfas, Warren 
and Ames (42) in a study of the effect of large doses 
of mucleic a.cid. Their etudj.es of t he bone marrow show-
ed cle8rly a chemotactic effect of the nucleic acid, 
with the massing of leucocytes around the patent sinus-
oids" a marked diapedesis into the vessels, 8nd the 
vacant areas of the marrow from which the granulocytes 
had been dr8wn. They then found that the granulocytes 
could be called from the marrow by the~plit products 
of nucLeic acid, adenine ~md gU8nine nucleotide. From 
this they conclude that nucleic apid and its deriva-
tives are important physiological factors in the chem-
otactic action, and thpt the showers of non~motile, 
• 
~ragile leucocytes in the circulating blood mar give a 
rythmic discharge of such prOducts into the circulation 
pnd so be responsible for the rythmic diseh8rge of leu-
cocytes from the bone marrow whi.ch actuelly occurs 
normally. 
However, of the maturation factor there is but little 
known. The physiological maturation factors for white 
cells are not known, but Sa.'bin (35) has postulated that 
,those bacteria th8t produce a sustained leucocytosis 
introduce such a factor for they produce an increased 
ai vision, growth, snd maturing of the less mature myel-
ocytes in the marrow far beyond normal counts. Novy 
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and Eppler (43) consider tht:lt the m~:tturation factor 
comes from altered body protiens and not from factors 
introduced into the bOdy from the outside. 
Certainly the modern aspect of the problem involves 
a shift in emphasis from the morphologica.l study to the 
investigation of the chemical maturation factors. These 
chemical fa.ctors should be sought in bacteria known to 
affect blood cells, in certain organ extracts, as well 
as in specific dietary fa.ctors, some of which may be 
vi ta.mines. Such a knowledge of these ~emical factors 
should unravel the conditions which underl~e abnormal 
changes in mechanism, for example, granulocytopenia. 
ETIOLOGY 
Since the first report of Schultz (3) in Germany 
thirteen years· ago and the report of Lovett (44) in the 
United States but eleven years ago, cases of granulocy-
topenia reported have been constantly on the increase 
until in 1934 Kr~lcke and Parker (45) collected reports 
of 473 Cases from the American and Cana.dian literature. 
With this increasing frequence, many investigators have 
directed their efforts toward the solution of the etio-
logic tactors. The following presents a review of the 
work which has been done in this field. 
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1EOGRAPHIC DISTRIBUTION: Parker and Kracke (45) 
heve collected from literature reports of 473 cases 
from 1922 to 1932 inclusive. They report an increasing 
number of cases each year probably because of the larger 
number of cases and its more widespread recognition. 
During this same period there have been reported Borne 
350 cases in GGrma.ny, 100 cases in France and but 6 cases 
in England. Dennis, in a personal communication with 
Kracke (45) reported 2 cases observed.in Beirut, Syria 
and states the physicie.ns from Palestine and Eygpt had 
seen cases. The rarity of the disease in England is sig-
nificant and will be referred to le.ter. Granu1openit:l 
seems to occur chiefly in the United states and Germany. 
AGE, SEX, and RACE: Fitz-Hugh and Comroe (46) in 
a series of 18 cases find the average age to be 48.1 years, 
the youngest 19 and the oldest 78. Madison and Quier 
(14) in a ceries of 14 cases, the youngest 22 !'>nd the 
oldest 80, give an average age of 51 years. Kracke and 
Parker (45); from their report of 473 cases, find the 
average age to be between 40 and 50. These authors find 
thet the disease occurs in a retio of two females to one 
male. Kracke (45) reports only 8 colored cases to 465 
whites. None of the authors report any sea.sonal variati ons. 
OCCUPA'IlION: Pl?rker and Kra.cke (45) make the follow-
ing statement: II It is a striking fact thctt gr~mulopenia 
is more prevalent among physiCians and their relative$, 
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nurses, hospital employees, and medical students than 
in any other group of people. Based on the 1930 popu-
lation census of the United Sptes, it occurs 50 times 
more frequently in physicians than in tea,chers .11 
Me.dison and Squier (14), Stelhorn and Amolsch (47), 
Harkins (9), and Conner and associates at the Mayo 
Clinic (48) and others who have made a study of the 
di sease (46), he.ve all ffietde the remarkable observation 
thet many of the patients were members of the medical 
or allied professions, or were relatives or friends of 
physicians. These men have also repeatedly called at-
tention to the fact tbP t this disease occurs for the 
most part in the better class of our people. 
BACTERIA: Lovett (44) in 1924, noted in her case 
the presence of mouth ulcers infected with B. pyocya.neus 
and at once suspected this organism ~tS etiologic. S~e 
injected numerous la.boratory animals but failed to pro-
duce the condl tion. Windham (49), Keeney (50), s.nd 
others have made similar observations. 'rhese findings 
have led many to suspect it as an etiologic factor but 
up to t he present time efforts to reproduce the disease 
in laboratory a.nimals with it, has been unsuce-essful. 
Kracke and Parker (45), from their report of 473 
cS.ses, find 74 of the cases to have positive blood cul-
tures. Among the infecting organism were 26 different 
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types~ which illustrates the wide variety of infecting 
organi sms. Fr'ied and Dameehek (5), reported the experi ... 
mental production of granulocytopenie" in rabbits by the 
intravenous injection of Salmonella Suipestifer. How-
ever they failed to produce a sustained and prolonged 
depression of the leucocyte count but only ft temporary 
depression, which has well been demonstrated to follow 
the injection of (3,ny killed organisms or other matter 
in a finely divided state • (23) 
There are many reports in literature concerning the 
efforts of various investigators to reproduce the disease 
in laboratory animals with organisms th2t have been iso .... 
la.ted from their respective pe.tients, but all this work 
has been unsuccessful. Piersol and Steinfield (23), 
injected intravenously into rabbits inactivated cultures, 
Berkefeld filtrates, and supernatant fluids of cultures 
of many organisms and failed to reproduce the conditioh. 
They called a.ttention also, to the fact that a temporary 
leucopenia may be produced by the injection of peptones 
t'md a large number of other protiens. 
Since the works of Ruedeger (52) in 1905, Nakayama 
(53) in 1920, a~d Gay and Dram (54) in 1931, it has been 
known that continued absopption ci: toxins from s1 tes of 
focal infections has the property of destoy1ng white 
blood cells, particularly granUlocytes. To this toxin 
they gave the name of leuco6idin •. Dennis (55), was par-
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ticularly impressed by their findings and in 1923 re-
ported a series of experiments in rabbits which show 
great promise. From Dennis' study of other cases report-
ed in literature, he learned th~t the bacteria most 
often present were Streptococci and Staphlococci. He 
felt that if via,.ble cultures of such orga,nisms could be 
enclosed in /3, membrane which would permit egress of only 
the soluble products of bacterial metabolism, leucocidins, 
thet experimental agranulocytosis could be induced. He 
brought about this condition by injecting a living eigh-
teen hour culture of organisms into plOtrchment capsules 
and sealing the punctures with celloidin. After a thor-
ough soakir;tg in 70 percent alcohol, these capsules were 
introduced into the 8.bdomina,1 oa.vi ties of twenty rabbits, 
through small incision made under aseptic conditions. 
Two rabbi ts received capsules of sterile broth a.s con-
troIs and were entirely negative. Staphlococcus aureus, 
streptococci hemolyticuB, Streptococci viridins, and B. 
proteus asiaticus were sepa.rately used" all producing 
granulopenia. strep. viridins produced, in two animals, 
a syndrome practically identics.l with acute clinica,l 
granulocytopenia, termlna.ting fatally. From this, Dennis 
suggests that granulocytopenia. in man is due to the a-
ction of leucocidin rather than a specific microorgan-
\ 
ism. 
The injection of dead bacteria in the course of 
vaccination has been suggested as a possible cause. 
Bromberg and :Murphy (56), Kre.cke (57), and others have 
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reported typ:1,cal cases following typhoid vaccina.tion. 
However, these cases had received consideretble previous 
meo.ica tion. 
GLANDULAR DYSFUNCTION: The influence of the en-
docrine glands on the output of both granulocytes and 
eryth;rocytes has been studied considera.bly and ba s long 
been suspected •. Jaffe (58), studied a patient with gen-
. eraliz,ed infiltration of lymphadenoma which included in-
vasion and destruction of the adrenal cortex with the 
patient finally dying with a typical granulopenia. He 
infers from tl1is thc'3t the granulopenia was due to a cor-
tical adreni3.1. insufficiency. Britton and Corey (59), 
ha.ve reported that a.drenal insufficiency in cat s resul t-
ed in a marked degree of neutropenia with t he return 
of the granulocytic level.to normal following the ad-
ministration of cortico-adremtl extract. They did not 
hO\~iever produce the typical granulopenic syndrome. Kunde 
and others (60) have noted the production of hypoplastic 
and aplastic bone marrow 'in thyroidectomized rabbits. 
Hubble (60) postulates that bone marrow depression may 
be caused by a pi tui tary basophilic insufficiency, a.nd 
he states th t there is much evidence to indicate that 
granulopenia may be caused by cortico-adrenal dysfunction. 
Evidence accumula.ted indic8tes tha .. t the ductless glands 
ma.y pla.y a pa.rt in the etiology, however, this concept 
will have to await further ·confirmation. 
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RADIATION: Excessive exposure to radiation has 
been suspected as a possible etiologic factor although 
it is sometimes used in minute quantities in the treat-
ment of the disease. (45) 
ALLERGY: A few authors believe that gra.nulocyto-
penia may be a form of allergy in which the 'bone marrow 
is the point of least resistance. Shilling (19) pro-
duced a blood picture similar to tha.t of granulocytopenia_ 
experimentally in a.naphylaxis, so that he thinks it may 
be an anaphylactic reaction instead of an individual 
disease. 'rhe c a.se s of Bromberg and Murphy (56), as well 
as Kracke (57), who received typhoid v!9.ccine, have al-
ready been mentioned. It is possible these cases may 
have resulted from an overwhelming reaction to foreign 
protein in a sensitive subject, however it is interest-
ing to note that in a.ll these cases there had been pre-
vious dr~ therapy. 
CHEMOTACITIC.AND MATURATION FACTORS: It has been 
previously mentioned that two different processes must 
be considered concerning the mechanism to maintain pro-
duction and destruction of granulocytes at a constant 
level(35): (1) the mechanism of delivery of cells to 
the circulation and (2) the mechanism of maturation. 
Fitz-Hugh end Krumbna.ar (62), from autopsy study of the 
bone marrow are of the opinion tha.t there mB.y be a de-
finite hYperplasia up to the myelocytic level but that 
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matur8tion ce8.ses at that pOint. Rosenthal (65) and 
Kracke (64) have independently reported cases in which 
there was a definite hyperplastic bone marrow at sternal 
puncture at a time when there was a peripheral neutr-
openia. Beck's conception of such c's.sis is as follows: 
In typical cases of malignant neutropenia with myeloid 
aplasia, the part of the bone ma.rrow that manufa.ctures 
the granular leUkocytes, level I, has ceased to function, 
or nearly so. The life of the granular cells of the 
blood stream being but from 3 to 5 days, when level II 
and III a.re exhausted, the granulocytes of the blood 
strea ..m will tota.lly disappear in from 3 to 5 days there ... 
after. There is little evidence tp...a t the granulocytes 
B.re abnormally destroyed in the blood stream. The bulk 
of the evidence pOints to the fact that the primary 
lesion, sO far as is known is the granulopoetic area of 
the bone marrow, and that this condition precedes the 
c1inica.l symptoms and loca.l infections. She reasons 
that the primary lesion is not in the bone marrow but 
in the organ or tissue which give rise to the substance 
(maturation factor) that keeps the gra . TIulocytes to a 
normal blood level or keeps the destruction and produc-
tion at a constant level. She points out that the text 
book picture of pernicious anemiB. can very aptly be sub-
stituted for that of malignant neutropenia and as a ma-
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turation factor for erythropoesis has been found. so 
it rem/olins but to find the maturati on factor for gran-
ulocytes. She suggests that a chemical analysis of 
bacteria known to produce a leucocytosis might let:td to 
a solution but that it seems more 10gica.l to seBrch 
within the bocly for the particular organ extJ:'act re-
guleting granulopoesis. 
The other group of patients showing peripheral 
neutropenia with slight hypoplasia; normal, moderate, 
or marked hyperplasia of the myeloid tissue, S1:1e con-
siders as due to a lack ~ the chemotactic factor. 
The cells my be growing and ma.turing but are net being 
. called to the circulating-blood. The normal stimulus 
for calling the granulocytes from the marrow to the cir-
culating bood has been shown by experimental work (42) 
to be the liberated products (nucliec acid, adenine, 
guanine, and etc), from disentegrating granulocytes in 
the blood streB.m. This theory, she points out, could 
account for failures in the treatment of pa~tients with 
nucleotides who clinically were similar to those who re-
covered under such trea.tment. If the maturation factor 
is absent, a chetnotactic factor would be of Ii ttle value. 
CHEMICALS: It has long been known that various 
chemicals wil], depress the bone lJI'rrow function, result-
ing in partial or complete inhibition of one or all cel-
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lu19r types. Farley (10). gives Labbe e.nd Langlois the 
credit for describing the first case of depression of 
the bone marrow function following the use of arsphen-
amine. This was in 1919, just nine years Ffter the in-
troduction of salvarsan and neosalvarsan by Ehrlich. 
Since ths.t date, up to and including 1929, Farley collect-
ed 39 such cases from literature. Of these, 23 patients 
died and 16 recovered. 'rhe symptons varied from those 
of purpura hemorrhagic a to those of severe aplastic 2-
nemie, and malignpnt neutropenia, depending on whether 
the principal effect was on the granulopoetic, megakar-
yopoetic, or erythropoetic tissues or on all of these 
combined. Farley summarizes his cases·in saying that 
it 5eems likely that the direct cause is the disinte-
gration, in vivo, of the arsphenamines 80 that a. benzol-
like action ta.kes place, end suggests tJ:1..at the rarity 
of occurrence may be explained on a preceding weakness 
of the hemopoetic apparatus of the individual. 
Selling (65) in 1910 repqrted three cases of ben-
zene pOisoning, cher8cterized by granulocytopenia and 
complicated by purpura ~md hemmorhages, in girls work-
ing in a rubber factory. One of these girls had Quit 
her work long before, which illustrates the delayed 
and cumulstive effects <;>f the Chemical. In 1916 Selling 
(66), experimented with benzene by subcutaneous injec-
tions into rabbits and demonstrated the production of 
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leukopenia '.l1i thout an erythropenia. Since 1910, 
benzene pOisoning has become ~ fairly well recognized 
syndrome to the medical profession with num~rous re-
ports of cases. These cases for the most part show a 
depression of more than one of the bone marrow functions. 
In 1932 KrEtcke (67) Wf'S able toproduce a selective act-
ivity on the granulopoetlc tissues without disturbing 
the erythroctic and thrombocytic element.s. 
There have been numerous ceses reported from France 
followi~g the injections of certain~eparations of gold. 
(45) 
'rhe fact thet typical granulopenia C8.n be produced 
by gold preparations, by arsphena.mine. and by coal tar 
derivities (to be substantiated later), all of which 
contain a bonzene ring is evidence that all of these 
SUbstances must have some common factor which manifests 
a selective activity on the granulopoetic tissue. In 
following this hypothesis it may be well to outline 
briefly the works of Kracke and Parker (45), in which 
they studied the relation of drug therapy to granulopenia. 
From reports to a questionaire, they gathered that 
there exists almost a direct proportion between the in-
,cidence of granulopenia Bnd the incidence of usage of 
drugs containing the benzamine (benzene amide group) 
group, ie .• , 3 out of 4 nurses or 3 out of· 5 physiCians 
but only lout of 4 laymen and lout of 8 negroes will 
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select a c08.1 t~u· drug for use as an an81gesic. They 
feel th&t the prevBlence of the dlsease in the United 
States and Germany parallels the usage of coal tar 
drugs, while in Eng1a.nd these d rugs are used but Ii ttle. 
These drugs have been introduced only in the last ten 
or twelve year period which corresponds to the period 
of granulopenia. 
It is there opinion that it 1s not the direct a,ction 
of benzene that produces the depressant action upon the 
bone marrow, but the a.ction of one of the oxids.tion pro-
ducts of benzene. In support of this contenti6n, they 
injected rabbits SUbcutaneously with mixtures of equal 
parts benzene and olive oil a nd upon I:ma.lysis 18 hours 
later found only traces of benzene but considerable phe-
nol and catechol. Control animals showed these substances 
to be absent. ?urthermore, the bone marrow of the in-
jected a.nimels was analyzed and showed the presence of 
both phenol and catechol but no trace of benzene. Con-
trol animals were negative in this case also. 
The oxidation of hydoquinone or c8.techo! to p~u"a­
quinone and orthoquinone respectively can easily be car-
ried out both in vivo and in vitro. In vitro the re-
action is activated by the enzyme phenolase which is 
present in the leucocyte. This progressive oxidation 
is illustrated on the accompanying chart beginning with 
the original substance, benzene. 
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Oxidation beyond this point would break the ring 
end so reduce the serious toxic action. The relation 
of coal tar deri vi ties to granulopenia, has previously 
been mentioned. These d rugs all have substituted a.mine 
groups on the benzene ring which make them primary a.mines 
and are designated as IIbenzamine drugs H • The benzamine 
drugs include neoarsphenamine, arsphenamine. acetanilid, 
phenacetine, and amidopyrine. There structual formula 
can be studied from the chart. Tl::e amine group set s 
these benzamine drugs apart from other coal tar derive-
tiE'S, such a.s aspirin which do not heve such a group, 
because of the much greeter ease under which oxidation 
c!:m occur. Kracke end Parker have worked out the possible 
oxidation products of the benzamine drugs in an B"ttempt 
to arrive at pn end-product com~on to all. The reactions 
are logical and sound ':chemically but hlghly theoretical 
physiologically in th8t they have not been proved to occur 
in vivo. The progressive oxidation products of these com ... 
pounds a. re illustrB.ted on the accompanying chart. The ox-
idation of phenacetine and acetanilid to para-amino-phenol 
has been established in vivo. 
Voegtlin (68) has well established that arsphenamine 
or neoarsphenamine, ,,'{hen administered intravenously, is 
readily decomposed by breakage of the double bond with 
the resulting formation of two molecules of arsenoxide. 
Kracke and P8crker theorizes on their furthsr oxidation. 
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Kracke and Parker have been able to produce mild 
and severe grades of granulopenia, experimentally by use 
of the oxidation products in only an oecasiont::Ll animal. 
However, they amend this f8ct by saying that one must 
rernember thqt not all laboratory animals have an infer-
ior bone marrow and the sa,me s1 tUB.tion may exist in the 
rabbi t 8,S in the human, namely, only an occ8.sional human 
being develops gra.nulopenia while many thousand of in-
dividuals have taken benzamine drugs indiscriminately 
and have shown no depression of the bone 'xaJ:'row • 
And so one may conclude that the etiology of 
locytopenia is still unknown. But that there has been 
much promising work done in the p8.st few years, the most 
outstanding of which includes Dennis' work on leucidins, 
Beck's work on the maturation and chemotactic factors, 
and last but probably the most importa.nt, that of Kracke 
and Parker on the benzamine drugs. 
PATHOLOGY 
The pa.thology of the di$e8se is in dispute. !.~uch 
of this confusion arises from failure on the pErt of many 
even to attempt the differentla.tion, either clinically 
or pathologically, of the verious conditions giving rise 
to the striking but far from pathognomonic sign that 
of extreme granulopeni D • Confusion also arises from too 
I 
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great reli9nce being placed on the interpretetion of 
stained emeers taken from the bone marrow. From smears 
of the bone marrow one gets absolutely no idea of the 
number or arrangement of the cells B.nd upon such factors, 
as well as upon the nature of the individual cells, the 
diagnosis of Bny marrow lesion must be based. Custer(69J, 
Peabody (70), and Jl:lckson and P2rker (71) have all ex-
pressed this seme opinion. Finally, the normal variations 
of cellularity from bone to bone must be recognized so 
thpt one will not make the mistake of pronouncing the 
bone ma.rrow ttaplastic ll from an examin8tion of the tibia 
alone. (71) 
Roberts and KrE'cke (72) say that there is a.n unanim-
1 ty of opinion that the essential pa.thology of granulo .... 
cytopenia is a marked and practically complete hypoplasia 
of the myelocytic tissues. In one of their cases, sternal 
puncture and smear showed a marrow entirely devoid of gran-
ular cells of any type, including even myeloblBsts. Dodd 
and Wilk1nson (73) state that the bone marrow is aplastic, 
but their case wa s a colored girl of eleven years w-1 th he-
-reditary syphilis who after treatment with sulpharsphen-
Amine developed extreme leukopen1e. This condition could 
hardly be called true idiopathic grsnulocytopenia. Schultz 
, 
often thought thet the marrow might be aplastic. However, 
Leon (74) who described the marrow in Schultz's CBses, 
merely says that there were neither TIE ture neutrophils nor 
m 
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myelocytes to be found a.nd that the femur was partly 
red, partly fatty. In the case under consideration, 
only the tibia or mid femur was examined so is it any 
wonder that the histological picture of the disease is 
regarded as confusing. 
Jaffe (75) found a bone marrow rather more cellular 
than normal with signs of marked degeneration in the gran-
ules of the myelocytes. He believed the ma.jori ty of the 
white ·cells to be myelocytes with a moderate or consider-
a.ble number of pIa sma cells and lymphocytes. Megaka.ryo-
cytes found in norma.l or increased numbers. F'i tz,-Hmgh 
and Krumbh[l.ar (62) as well as Jackson and Pa.rker (71), 
postulate a maturation arrest at the stem cell stage 
wi th the added possibility of Em end stage which might 
be regarded as aplastic. 
Jackson and Parker (71), after an examination of 
the marrow from twenty-five cases dying in various stages 
of what seemed clinically and hematologically to be class-
10al agranulocytosis, make the following generalizations. 
They found the marrow of the vertebrae, ribs, sternum and 
mid femur essentia ..lly the same. 'rhe degree of cellularity 
was usually norma.l. Rarely the femur remained fatt.y as 
in the normal a.dult. They thought that in such instances 
death occurred too 80 on for the marrowl::wti vi ty to spread 
peripherally. In some sternal and vertebral merrows, 
particularly in patients dying later in the d~sease, a 
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certain amount ofbypoplasia existed. On the other hand 
in the fulminating cases the marrow was perhaps unusu~tlly 
rich in cells. The degree of-cellularity, however, varied 
but little and they think this fElct to be of minor import-
ance. They found little or no cHsturbance in the red 
cell series. Erythroblats, normoblasts and nuclepted red 
cells occurred in nortr.al or slightly increased numbers 
and showed no abnormal features. The megakaryocytes aslo 
"{{ere found in the usua.l numbers and histologically eppear-
ed perfectly normal. Rotter (76) ,and Jaffe (75) agree 
wi th the la.tter. However Robert s and Kracke (72) are of 
the opinionthpt the hemorrhagic tendency which they re-
gard as a very common sympton of the disease may be traced 
to a marrow disfunction involving megakaryocytes and a de-
crea se of platelet formation. 
Jackson end Fark~r report that the most marked bone 
marrow changes naturally occurred in the cells of the grl:m-
. 
ular series. No mature granulocytes either neutrophils 
or eosinophils, were found in any marrow, nor were there 
any true myelocytes. Very rarely they report a promyele-
cyte. Practically every cell belonging to the granular 
series was a stem cell. Occasionally, in patients dead 
from pulmonary embolus, sepsis, or some other complication 
they found myelocytes, metamyelocytes, and young neutro-
phils in profusion throughout the bone ID8rrow which weS 
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generally hyperplastic. But in those cases which, at 
the time of death, showed extreme leulopenia a.nd gran-
ulopenia, only stem cells, plasma cells or lymphocytes 
"If,rere found. Fitz-Hugh and. Krumbhear (62) contrue this 
fact to evic.ence a maturation arrest rather tha.n B. fail-
ure of delivery of cells into the blood stream. Jackson 
and Parker agree with this theory. The parent cells were 
often seen in active mitosis but further maturation was 
denied. 
In those patients who survived the ravages of infec-
tion for a considerable period (eight to twenty days) the 
bone marrow picture was somewhat different. It was then 
found to be relatively hypopls.stic. (j'radual1y as the 
diease progressed the stem cells dimished in number and 
their place was taken by lymphocytes a,nd plasma cells 
8nd in cases dying 8S lete as the fifteenth day after 
the apparent onset of the disease these cells constituted 
virtually the only white cells in the marrow. Rotter 
(76) is in egreeence with t he t?,bove findings. Pepper 
(77)' and Jaffe (75) stress the gegenerative changes oc-
curring'in the marrow. However other autho~s (71) are 
of the opinion that when such changes occur they are the 
result of bacterial invasion of the bone marrow itself. 
Beck (1) states that infection of the bone marrow in 
benign and malignant neutropenia has never been demonstrat-
ed except in termin8.1 septice:nia .• However she admits 
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thRt the 'Nork along t hi s line ha s not been exhaustive 
and further research may show this to be Fl. greet factor, 
especially in fulminating cases. 
The reaction in the spleen Beck (1) found to depend 
on the predominance of toxic or septic symptoms. In cases 
observed at autopsy, asplenlC tumor, partly of splenic 
character, was disclosed in some cases. Enlargement of 
the spleen in some cases she states as due to a great in~ 
crea se in the reticulo-end-thelia.l cells, which outnumber 
the lymphoid cells. The lymph follicles Bre not prominent 
on the cut surfa.ce. Microscopically, the sinuses are fill-
ed with erythrocytes, proliferating reticulo-endothelial 
cells and lymphoid cells. 'fhe liver, Beck· seys, ":nay be 
somewhat enlarged and show cloudly swelling. croscop-
iC8l1y, some cRset" have shown fatty degeneration, Bnd oc-
casionally s~Bll multiple foci of necrosis. There is an 
incre8.se in Kupffer's cells, 'rhere B.re bile cs sts .in the 
bile capillaries and bile pig~ent in the hepatic cells. 
Sometimes there are interstitial lymphatiC infiltrations. 
Hueper and Gerrison (79) describe the pethologic-
chRnges in the lymph nodes B.S follovrs: The submaxillary, 
cervical, peribronchial and mes6Bteric lymph nodes are in 
general enlarged and they sometimes contain hemorrhages. 
]j~icr08copic examinl:<tion reveals atrophy of the lymph fol-
licles; there a re no young lymphocytes in the germinal 
centers, only mature lymphocytes being present. There 
is a proliferation of the reticula-endothelial cells. 
SYMPTOMS 
A great many pe.tients give a history of weakness 
or lack of vitality for varying periods before the on-
set of the condition, especially in the chronic recurring 
cases. Some natients state that there wps a lack of en-
ergy for ye8.rs and a marked weakness for a few weeks or 
months before the onset of t he acute symptoms. On the 
other hand, neutropenia occurs in some patients who have 
alwa.ys been well 8.nd who were active physically and men-
tally until the sudden onset. (1) 
Beck (1) says that the usual mode of onset is mark-
ed by fever, chill 1:md sore throat, which may be sudden 
or gradual. To these may be added hea.dache, marked pal-
pitation with a tumultus heart beat, general aching, 
drowsiness and occasionally delirium. Some patients are 
nauseated end vomit, and, as a rule, there is dysphagia. 
There is an,_offensive, fetid odor to the bree.th, and 
the tongue is often h3avily coated. 
1'he patients a.re wilted in appearance; the skin 
is pale, but the mucous membranes e~re of goad color. 
The weakness, marked prostration end toxic appearance 
are out of all proportion to the few physical signs. 
Jaundice is rare in typical cases. The liver and spleen 
may be enlarged. The patients are characterized by weak-
ness, easy fatigue, drowsiness and tendency to infection, 
especially in the oral cBvity. Beck states tb.t there 
is evidence that just mere lack of neutrophile will 
CBuse euch symptoms as fever, wea.kness, inertia and men-
tel and physical collppse. Roberts and Kra.ck (72) found 
that complaints of weakness, exhaustion 8.nd fatigue were 
tWice as frequent in the neutropenic patients as in those 
showing a normal white cell count. Furthermore, they 
found that the severity of the symptoms paralleled to a 
reme.rkable extent the degree of neutropenia found. The 
fulminating cases are rapid in progress, with a oomatose 
concH tion usually preceding death. The di sease may last 
from three da.ys to three months, in rare cases 8. number 
of years, and end with death or with recovery_ The benign 
group usually correspond to the fatal group of cases as 
far as the early symptoms 8re concerned. 
Jackson and Parker (71) point out that the fever has 
nothing characteristic about it and most authors agree 
with this. As a general rule the temperature reaches a 
maximum of 103 0 or 1040 F. Ra.rely it may rise to 106 0 or 
even 107 0 F. In some pl';ltients only a very moderate hyper-
pyrexia is the rule. A steady, high, unremitting temper-
ature is of extremely grave prognostic import. 
The local lesions seen in bEnign and malignant neu-
tropenia usually occur on the mucous membrenes, more rarely 
on the skin. Lesions of the mucous membranes when present, 
are localized mainly in the mouth and involve various 
structures, such as the gums, tonsils, soft pa.late, lips, 
pharFnx and .buccal mucous surface. Yore rarely the nose, 
uterus, vagina, rectum, anus and skin are invovled. Lo-
cal leeions may also occur any place along the ga~tro­
intestinal tract or in the lungs and the symptoms are 8.C-
cording to the areas involved. 
Owing to the absence of neutrophils there is none 
of the usual inflammatory reactions about the ulcerstions. 
But a peculiar brawny edema ~aj be most extensive and 
in the throat constitutes a grave menace to the patient's 
life. This €~dema., as stressed by Jackeon and P!',rker (71) 
may be so great and so extensive as to preclude the pos-
sibility of swallowing and render breathing well-nigh im-
possible 
There may be regiona.l adenopa.thy with nee'rosis and 
sloughing of the overlying tissues and skin. The tonsils, 
when involved, have in some case's sloughed away. Gan-
grene Bud consequent sloughing may occur: this is par .... 
ticularly dangerous event when it occurs in the gastro-
intestinal tract. Two patients in the series of Jackson 
and Pa.rker (71) died from rupture of a necrot ic intestine. 
In one the blood picture had tHready become norma.l too 
late, however, to be of avail. 
The classical clinical description given above is a-
greed upon by most authors some of which are Beck (1), 
Jackson and Parker (71), Jackson H. Jr., (79) Baldridge 
a.nd Needles (16), Ka.stlin (7), DORn (80), a.nd Fitz,-Hugh 
and Comroe (46) .. 
In a series of 103 cases reported by Jackson and 
P~rker they ~ound the following blood counts. (71) The 
white count was rarely as high as 2500 per cmm. and is 
often 1000 or less. Frequently it is in the hundreds. 
'::'hirty hF.td white counts less than 500, twenty-eight had 
white counts between 500 and 1000, thirty-eight hRd white 
counts between 1000 and 2000, and only seven had white 
counts of between 2000 and 3000. Neutropenia of an ex-
treme grade was the rule. Only seven of their cases 
showed neutrophils of over 5 per cent at the height of 
the disease. Eosinophile were I' ather consistently ab-
sent. Such neutrophils as remained were old end often 
degenerated. The majority of the white cells present 
were lymphocytes, for the most part of the e.dul t type. 
Most authori ties agree that in the t'rue di sea se 
there is little or no material alterRtion of the red 
blood cell picture, or 8.ny notable diminution of the 
platelets. (.7), (76), (81), (82), (71) •. Aubertin and 
Levy (83) find, on the other hand, a constant thrombo-
penia and Roberts and Kracke (84) believe that the plate-
lets are markedly reduced. Most authors pOint out that 
such cases of reported thrombopenias are to be regarded as 
an indication that some other disease, notably aplastic 
anemia or acute leukemia, is under consideration. 
-. 
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DIAGNOSIS 
Neutropenia must be diagnosed early if the morta-
lity is to be reduced. There should be more critical 
cytologic examinptions of the blood, as there is much 
evidence in the literature that the neutropenia pre-
cedes all other symptoms. To wait for the appearance 
of sore mouth, sore throatJ fever and prostration is 
only giving the army of orgc1nisms time for invasion. 
Ifhe patient is usually ill from several days to several 
weeksJ or perhaps months, before the acute stage in 
many cases. The symptoms and blood picture are as char-
acteristic as 'those occurring in pernicious anemia in 
most typical c'ases. The symptoms and blood picture have 
already been referred to and will not be repeated at this 
time. The rule should be to follow up each case of con ... 
tinued fever with frequent leukocyte and differential 
counts. If angina and fever are both absent and there 
. only weakness, malaise, a.nd dra.wsiness, a frequent 
leukocyte and differential count should be made. The 
diagnosis is made on the low total count end the reutro-
penia. Burcky (5) goes so far as to say that the diag-
nosis of agranulocytosis can be definitely made only when 
the white blood count is greatly reduced, usually below 
1000 cells per cubic millimeter, and when the granulocytes 
are either completely absent or found in very emaIl numbers, 
and usually abnormal in character. The presence of such 
symptoms as great prostration, necrotlc TImcous mem ... 
braneulceretlone, and high fever, he says, are very 
important corroboratory flndi:ngs. 
P:ZOG1\TOSIS 
The prognosis of agranulocyts,is is extre~fiely grave", 
t t "" 1 I r:- \ S 8 es ourCKY \~) in pn article published in 1935. He 
points out that before the use of the present theraphy 
(nucleotides), the mortelity rp,nged between 80 and 90 
per cent for first ~ttack with recurrences the usual 
thing~ nearly always terminating fatally. Kastlin (7) 
in 1927 gave the mortality as 95 per'cent. 
Harkins (9) in 1931, reviewing the cases in liter-
ature, obtained a ~ortality of 82 per cent. In the same 
year, Rosenthal 63 reported a mortality of 46.2 per cent 
in a series of twelve "malignant ll and fourteen IIbenign ll 
09 ses. . The S8,me year Taus sig B.nd Schnoebelen (57) in a 
review of 328 CBses found a mo~tality of 75 per cent in 
CB ses without spec'ial therapy and mi scella.neous forms 
of treatment; 63 per cent with trans:fi'usion; end 53 per 
cent with Roentgen treatment.. With t he introduction of 
nucleotide therapy the prognosis he's become more favor-
able. Jackson and Parker (7l) in 1935 report a mortality 
of 33 per cent in a series of 103 CBses receiving such 
tree tment. In ce ses presumably c'hle to d rug therapy, the 
mortality is nearly 100 per cent with the continued use 
of the drug in question. (14) 
It is evident tha.t with the loss of immunity to bac-
teria, the loss of strength, the prostration of the men-
t8l function, the rising fever and the quick sepsis, that 
death is ineviteble unless a new crop 6f granulocytes is 
quickly restored to the blood stream. This becomes more 
difficult 8.S the total white count and granulocyte count 
falls. The more favorable prognosis since 1927 can un-
doubtedly be attributed to two factors: first, the earl-
ier diagnosis of the' disease, and secondly, the use of 
nucleotides as a therepeutic measure. The increaseing, 
use of blood counts should cause the mortality rate to 
continue to decrease. 
TREATMENT 
The treatment of any disease, t he pathogenesis and 
na,ture of which is uncertain, is at best unsatisfactory 
and more so when t he.t condition may be easily confused 
with other pathologicql entities of a probl'lble different 
fundament 131 nature. Many mea,sures have been advocated to 
combat granulocytopenia. NGne is apparently specific. 
Almost all authorities agree that the major problem is 
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thset of restoring t he bone marrow to its norma.l B.ct-
lvity end thus raising the peripheral white count; for 
the 10s8 of leucocytes removes one of the body's great-
est defenses against infection. Without bone marrow 
recovery, there can be no cure. 
NON-SPECIJ:"IC 'rHERI1FY. The injection of sterile 
milk, turpentine, reticulin, metaphen, and formic acid, 
in conceded by almost everybody to be useless. Doan 
(80) in 1932, found a mortality of 74 per cent in 178 
patients receiving such treatment. That one gets a 
white cell response in normal patients by such therapy 
is not the slightest reason for supposing the.t a similar 
response should occur in granulocytopenie. where there 
are no neutrophils in the bone marrow to call forth. 
The probsble effect of such treatment in normal patients 
is chemotactic end not an increase production of white 
cells. Doan (80) compiled mortHlity statistics on a 
large group of patients which received vprious types of 
treatment. His figures are as follows: 
THEHAPY CASES DEATHk3 :'1: ORTAL I'fY 
Untrel3ted ;\~~any ;v.Ieeny 90 
7\1iscelleneous therBpe:utic 
measures 178 133 74 . 
Arsphenamine 33 24 72 
Blood Transfusion 33 34 64 
Irradi9tion 64 34 53 
Xucleotide 44 11 25 
'J'he tb...ree most efficacious methods of treatment as 
?0 
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gathered from these s:tatistics would be blood trana-
i 
fusion, irradiation and nucleotides. Doan suggests 
! 
that these three ther,apeutic measures must have some 
common fs.ctor which i,s the a.ctive principle, He sup-
poses that nucleotide, is this specific princlple and 
! 
explains its presence in the follo.ving manner: In 
blood transfusions, n~cleotide is introduced in small 
quantities in sOlutior (85) and formed by disentegration 
of white cells. In irradiation, he supposes that auto-
! 
genous nucleotide is liberated by the destruction of in"'" 
tact myeloid focii. With this hypothesis in mind let 
us review these more !specific treatments of granulocyto-
penia. 
TRANSFUSION. T!ransfusionof blood he s been endorsed 
by many authors amongi which be ve been Hueber (86), Peper 
I 
(77), Fitz-Hugh B.nd Ciomroe (46), end Taussig (87). With-
i 
out question recoveri:es have follOWED. blood transfusions 
, 
but aside from this there is no evidence that transfu-
sions heve a. stlmulatiing effect upon the bone ma.rrow. 
Jackson and Parker (7!1), even go so fa.r as to state that 
it is not an uncommon! experience to find the peripheral 
whi te blood count lowier after transfusion than before. 
I 
They state that the' ~ortality in their series was the 
same for the group rejcei ving both transfusions B.nd 
pentnucleotide and fOr these receiving only pentnucleotide. 
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In the last three Or f.our years the enthusiasm of the 
efficacy of blood transfusions has been lost in the 
greater enthusiasm for pentnuc1eotldes (71), (88), (89), 
( 5) • 
X-RAY. Stimulating doses of X-ray have been advo-
cated ~y many (89), (87),(90), (91). Friedmann and 
Elkeles treeted 43 cases with irradiat5.on with a mortal-
ity of 32 per cent. Taussig and Schroebelen had a mor-
tality of 50 per cent in four cases. Licklerstein treat-
ed 20 cases with improvement in seven but a year later 
only two were ali ve--s mortali ty of 90 per cent. Heuber-
(86) enthusia.stlcal1y recommends radiation. Reznikoff 
(92) has expressed the idea and Jackson and Parker agree 
(71), that even small doses of X-ray tend to depress the 
marro wand they point out that four or five days must 
elapse before the effect s of any mature.tion element can 
be detected in the peripheral blood. It is usually claim~ 
ed by advocetes of r8.diation that favorable changes occur 
vdthin a few hours. When such changes occur Jackson 8D;d 
Farker 8.ttrlbute the rise as spontaneous, or, if actually 
du~ to radiation, to a redistribution phenomenon rather 
than a maturation factor. Like tre.nsfusion, X-ray therapy 
has come to be disapproved in the last few years. 
LIVEH EX'l'RACT. Liver extract has been advocated by 
many, F'ors.n (93), injected the e(~uiv~;llent of' 100 grams 
, 
of liver into the veins or muscel every 8 to 12 hours 
until a definite rise in the white count h~d taken place. 
Four C8 ses were appa,rently successftllly treated. How-
ever, C ':; ge shAll's (94) C8. se fa iled to respond to six 
vials of liver extract intravenously each day. Four of 
the pc,tients in Jackson and Parker l s (71) series received 
liver extract BS well as pentnudleotide yet all died. 
Silver-·(95) treated a case appa"rently due to dini tro-
phenol without benificial results. Eonsdorff (96) treat ... 
eO. two cases with liver extract with recovery in both 
instances. However Parker (71) poin~s out that one case 
vms probBbly a perniciOUS anemia and the other due to 
nov8rsenobenzol and bismuth which when removed may have 
been of considerable prognostic importance. Walker (97) 
stetes thet the value of liver therapy is doubtf'ul be-
cp.use it is not known defini tely if it ha.s a stimulating 
effect upon granulopoesis. However he thinks it does 
no harm, and in cases of anemia is beneficial. 
NUCLEOTIDES. liThe history of this remedy goes back 
to the day s of frequent sep:::1i sand 'laudable I pUSH, sa.ys 
Walker. (97) Pus was easily obtained in those early 
days, and from it nucleic acid was prepared, being so 
called becs.use it .wa s believed to be chiefly derived from 
the nuclei of leucocytes and other cells. Later it was 
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found that nucleic acids occur in combination with 
various protiens in the form of nucleoprotiens. By a 
process of hydrolysis the purine bases adenine a.nd guanine 
were isolated, and derived from these products was pentose 
nucleotide, found to exist chiefly in the nuclei of living 
cells. In 19~4 Jackson (85) definitely demonstrated the 
presence of pentose nucleotide in normal human blood. 
In 1930 Reznikoff (98) advocated the use of adenine 
sulphAte in the treatment of granulocytopenia.. In 1933 
(99) he summarized the results in fifteen cases with 
eleven recoveries. He also treated eight ~ases in which 
the diagnosis was doubtful, ''!1th but one recovery, and 
twelve C8.ses complicating other diseases, '0t i th two re-
coveries, a.nd these only temporery. Hi s conclueions 
were conservatively optomistic. The treatment with aden-
ine sulphate consists of dissolving one gram of the salt 
by boiling two or three minutes in 30 to 40 cc of normal 
saline solution, allowing to cool slightly, filtering 
through a erne II adapter containing cotton to filter out 
all undissolved crystals, and injecting intravenously 
while still warm (105 0 to 1100F.). This dose is to be 
used three times a day for At least tb.ree days. (5) The 
drug is non-toxic, gives no disagreeable reaction, and 
may be used in the presence of myocardial disease. 
Inasmuch as it had been shown by Doan, Zerfas, Wa.rren 
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and Ames (42) in 1928, that pentose nucleotide could 
definitely raise-the peripheral white count in normal 
animals, Jackson and his co-workers (100) decided to 
try the effect of this sUbstance in those conditions 
characterized by extreme leukopenia. In 1931 they re ... 
ported the results of such therapy in twenty eases of 
granulocytopenia with fourteen recoveries. In 1932 
they (101) re~orted on 69 cases treated with pentose 
nucleotide (iQcluding the original twenty) with a total 
mortali ty of 26 per cent. Since 1932 Jackson a.nd Parker 
I 
(71) have sdd~d 34 cases to t his series making a tota.l 
of 103 cases \~ri th a mortality of 33 Del' cent. Only those 
cases treated for less than 48 hours or those which died 
of some entir,ly unrelsted disease were excluded. They 
have followedsll these cases to date (1935), including 
all deaths in. their mortality figures. 
Pentose ~ucleotide was introduced as "Nucleotide 
K 96 ft , but is'now marketed under the trade name of 
- i 
"Pentnucleotide ll • It is obtainable in 10ce. rubber-stopper-
! 
I 
I 
ed vials,. each containing the equivalent of 0.7 grams of 
I 
I 
the Bolid mat$rial. In the average case of granulocyto-
I 
penia with a .hite count between 1000 and 2000 per c.mm., 
0.7 grEtm i B given intramuscularly two, or preferrably, 
! 
three times a I day until the white count ha.s definitely 
! 
i 
risen 'and 'yourflg neutrophilE! have appeared. This cha.nge 
! 
"~ usually occur~ on or about the fif'th d~ay oI~ trea .. tment. 
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0.7 grems is then given daily until the white count has 
been normel for severel days. In cases which are extremely 
sick, and e~pecially in those in which the total white 
count is below 1000, 40 cc. should b e given dAily until 
the white count has definitely risen and young neutropal1s 
ere present. Fifty cc. may be given even more advantage-
ously. The drug may also be administered intravenously, 
well diluted in saline, by the continuous drip method, 
the speed of injection being such that no untoward re-
adtion occurs. Usually 50 to 100 drops may be given per 
minute when 20 cc. ere diluted in 100 cc. of normal saline 
solution. The drug should be continued in larger doses 
until the white count has definitely risen and in some-
wha~ shaller amounts until it has been normal for several 
days •. If there has been no response in ten days, most 
authors consider further therapy useless. 
Fitz-Hugh and associates (46) report a reaction of 
81arming character but do not sta.te 'Nhether· the drug wa.s 
given intramuscularly or intravenously. They also say 
that one of their patients reacted violently with fever 
up to 104 degrees with e8ch intramuscular dose bvt tol-
erated the same doee intravenously without reactidn. In 
some, there is a transient sense of discomfort at the 
site of injection. In others there may be precordial 
distress, dyspnea and nausea. Very rarely are the symptoms 
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alarming. If however they are sufficiently severe 
syrr:ptoms to upset, the patient, Jackson and Parker (71) 
suggest that smeller doses of the drug be given at more 
. 
frequent intervals until the required amount is given 
daily_ They also point out that the drug should never 
be giv~n to an anaphylaotic individual nor to one with 
severe cardla.c damage. 
Doan (80) pOints out that the first sign of a favor-
a.ble reaction to pentnucleotide is evidenced by the a.p-
pearance of myelocytes in the blood stream. These cells 
may reach twenty per cent of the total white cells. This 
change, he says, usually occurs about the fourth day fol-
lowing treatment and corresponds in some measure to the 
reticulocytic rise in pernicious anemia. Shortly there-
after the temperature fells, the total white count rises, 
and more mature neutrophils tpke the pla,oe of the imma-
ture cells. 
Pentnucleotlde has been used successfully by many 
and at present is the treatment advocated by "!lost guthors. 
(102), (103), (104)', (105), (106), (107), (109), (93.).' 
G ENER.A.L CARE. It stands to reason that intelligent 
bedside ce.re, careful nursing, adequate nourishment, and 
fluids are all a necessary and o'rvious parts of the treet ... 
ment. The patient· must be protected in so far as possible, 
from infection. But attempts to sterilize the ulcerated 
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lesions is detrimental. Frequent washings of the mouth 
and throat ~ith soothing solutions may allay pain and 
make the patient mCJre cOf[;fortable. 
It had been suggested by some (Yi'"alker (97), Beck 
(1), Roberts and Kracke (lOg), thet Burgical interven-
tion is contra-indic8ted. Lintz" Thompson, Jackson and 
Parker (71), however, do not agree with this. They 8.d-
vise eny immediate surgery as would be done in a patient 
wi th B. normal blood count. 
CONCLUSION 
An 8tt~mpt has been made in this paper to review 
the literature on granulocytopenia and compile this in-
formation in more or less of a textbook fashion. A re-
view of the physiology of granulopoesis and pathological 
conditions occurring in granulocytopenia was given in 
order to gain a more ac·curete understanding of possible 
etiological fectors and the validity of each treatment 
presented. 
From this study, the following facts seem to be of 
primary importance: Whether granulocytopenia is to be 
regarded as a disease entity or a syndrome, cannot as 
yet be dogmatically steted, but it is probable that such 
a disease entity does exist. The etiology of the dis-
ease is as yet uncertain, however those particuls_r drugs 
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containing the benzamine nucleus undoubtedly-do have 
much to do with the development of certain cases. The 
I 
p~lthological changes in the bone merrow consists ofa 
maturation arrest at the stem cell stage. Effective 
specific treatment is as yet largely limited to the 
use of nuclleotides. The more favorable mortality in 
the past yew years has more or les8 pa.ralleled the more 
rapid diagnosis ~f ·the disease and the introduction of 
the use of nucleotldes in the treatment. Until' the 
nature, etiology and pathology of granulocytosis is un-
equIvocally placed upon a sound basis, the diagnosis, 
treatment and prognosis of the condition will remain 
little changed. 
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